AU Patent

AU2021401741A1 — Macrocycles and their use

Assigned to Blossomhill Therapeutics Inc · Expires 2023-06-29 · 3y expired

What this patent protects

The present disclosure relates to macrocyclic compounds, pharmaceutical compositions containing macrocyclic compounds, and methods of using macrocyclic compounds to treat disease, such as cancer.

USPTO Abstract

The present disclosure relates to macrocyclic compounds, pharmaceutical compositions containing macrocyclic compounds, and methods of using macrocyclic compounds to treat disease, such as cancer.

Drugs covered by this patent

Patent Metadata

Patent number
AU2021401741A1
Jurisdiction
AU
Classification
—
Expires
2023-06-29
Drug substance claim
No
Drug product claim
No
Assignee
Blossomhill Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.